Liver Cancer Trial, Recruiting (NCT05047510)

Liver Cancer Trial, Recruiting NCT05047510 Sponsor: Chinese Academy of Sciences Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05047510 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with liver cancer (hepatocellular carcinoma)
People who are planned to have surgery to remove part of the liver (hepatectomy)
People whose liver is functioning at a level classified as Child-Pugh A or B (a measure of liver health — confirm with trial site)
People whose liver cancer cells show high levels of a protein called GPC-3, confirmed before surgery
People aged between 18 and 75 years, with a life expectancy of more than 6 months
People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

People who have a known allergy to a dye called IRDye800 (used during the procedure)
People who have taken part in another clinical trial within the past 3 months
People who have been found to have another type of cancer
People whose heart, lungs, kidneys, or other major organs are not functioning well enough
People whose health means they would not be able to safely undergo liver surgery
People who the trial researchers consider unsuitable for inclusion for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 12 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-18201082715

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05047510

Sponsor: Chinese Academy of Sciences

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 86-18201082715

More information: https://clinicaltrials.gov/study/NCT05047510

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with liver cancer (hepatocellular carcinoma)
People who are planned to have surgery to remove part of the liver (hepatectomy)
People whose liver is functioning at a level classified as Child-Pugh A or B (a measure of liver health — confirm with trial site)
People whose liver cancer cells show high levels of a protein called GPC-3, confirmed before surgery
People aged between 18 and 75 years, with a life expectancy of more than 6 months
People who are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

People who have a known allergy to a dye called IRDye800 (used during the procedure)
People who have taken part in another clinical trial within the past 3 months
People who have been found to have another type of cancer
People whose heart, lungs, kidneys, or other major organs are not functioning well enough
People whose health means they would not be able to safely undergo liver surgery
People who the trial researchers consider unsuitable for inclusion for any other reason

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 12 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Chinese Academy of Sciences

Registry

ClinicalTrials.gov

Start date

10 September 2021

Est. completion

31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

HCC lesions

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov